1. Tagrisso gets the green light for first-line lung cancer treatment in Europe

    Industry NewsTagrisso (osimertinib) has been approved in Europe to treat Epidermal Growth Factor Receptor (EGFR) mutated non-small cell lung cancer (NSCLC) as a first-line treatment. 

    Read more »
  2. Keytruda (pembrolizumab) given accelerated approval for cervical cancer

    industry news

    Read more »
  3. Patients struggling with withdrawal symptoms may find new relief

    Industry NewsLucemyra (lofexidine hydrochloride), now approved by the Food and Drug Administration, may offer relief (and new hope) for patients experiencing withdrawal symptoms from opioid dependence.

    Read more »
  4. New relief for migraine patients?

    News updateThe first-ever preventative treatment for migraine in adults, Aimovig (erenumab-aooe) is now approved by the Food and Drug Administration.

    Read more »
  5. Imfinzi may offer patients benefits in earlier stages of lung cancer

    Industry NewsNew clinical results show that Durvalumab improved survival (versus a placebo) in patients with non–small cell lung cancer.

    Read more »
  6. All about Aimovig (erenumab-aooe): the unique new migraine treatment

    A new preventive migraine treatment, Aimovig (erenumab-aooe), poses promising possibilities for some migraine sufferers.


    Read more »
  7. Xeljanz (tofacitinib) approved for treatment of ulcerative colitis

    This will provide a much-needed alternative therapy for a debilitating disease with limited treatment options. 

    Industry News

    Moderately to severely active ulcerative colitis can now be treated with Xeljanz (tofacitinib), following the expanded approval by the Food and Drug Administration (FDA). This will provide a much-needed alternative therapy for a debilitating disease with limited treatment options.

    Read more »
  8. Mayo Clinic researchers make further step to a DNA test for liver cancer

    "We currently test for liver cancer using ultrasound and a blood protein marker called alpha fetoprotein," says John Kisiel, M.D., a gastroenterologist at Mayo Clinic. "Unfortunately, these tests are not very sensitive for curable stage liver cancers, and most patients who need this testing do not have it easily available or [are] not able to receive it often enough to be effective." The new advance by the team opens the door to further development of a DNA test. 

    New on a screen

    Read more »
  9. More information available to psoriasis patients in new label update

    This new development may increase chances of patients discussing the disease with their doctor...

    Industry News

    A new package insert that includes information/data about psoriasis in the genital area has been approved by the Food and Drug Administration (FDA). 

    Read more »
  10. New prostate cancer medication offers the same treatment with fewer side effects

    Men with metastatic castration-resistant prostate cancer (mCRPC) may have a new course of treatment available to them.

    TSM News Stock

    Read more »
Posts loader

Just one thing before you continue

Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

No, take me out of here.